-
Mashup Score: 3Meat for Mental Health Dr Philip Ovadia part1 - 1 hour(s) ago
Reach out to the interviewer for help with anxiety, stress, etc using nutrition tips, hypnotherapy, relaxation techniques GrowthFactor.org@gmail.comSocial:In…
Source: www.youtube.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0
May 18, 2024 — Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRM System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD) System and the EMPOWER Leadless Pacemaker (LP). As components of the mCRM System, the devices are designed to work together wirelessly to coordinate painless intracardiac anti-tachycardia pacing (ATP) therapy, provide rate-responsive bradycardia pacing support and to prevent sudden cardiac death without the risk of leads in the heart or under the sternum. Findings were presented at Heart Rhythm 2024, the annual meeting of the Heart Rhythm Society, and simultaneously published in The New England Journal of Medicine. In addition to evaluating the safety and performance of the EMPOWER LP as a standalone pacemaker, the trial evaluated the ability of the EMBLEM S-ICD System to successfully communicate a
Source: www.dicardiology.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0
May 18, 2024 — The Heart Rhythm Society (HRS) has announced the findings of three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AFib). PFA shortens operating times and may reduce the chance of damage to surrounding tissues with high safety margins. Researchers presented these findings as late-breaking clinical science during Heart Rhythm 2024 (HRS 2024), being held May 16-19 in Boston, MA. Atrial fibrillation is the most common type of arrhythmia, and by 2050, up to 16 million Americans are projected to have AF1. Contemporary guidelines recommend antiarrhythmic drugs as the initial therapy for the maintenance of sinus rhythm, but these medications are associated with serious adverse events2. Catheter ablation (thermal ablation or PFA) is an effective nonpharmacological alternative that is often, but not always, the second-line treatment if long-term medications or electrical cardi
Source: www.dicardiology.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3Home - SQUASHTV - 7 hour(s) ago
The official streaming platform for professional squash. Join SQUASHTV, and watch the world’s best squash, live stream and on-demand.
Source: www.squash.tvCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 12024 Updated Guidelines for Management and Treatment of HCM - 7 hour(s) ago
The American Heart Association/American College of Cardiology Guidelines for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy published in 2020 have been updated for 2024 to address certa…
Source: hcmbeat.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 52Vatican to reveal new rules for supernatural phenomena - 7 hour(s) ago
The new guidelines are expected to tighten the criteria for what counts as a divine apparition.
Source: www.bbc.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 6COVID "likely growing" in D.C. and 12 states, CDC estimates - 7 hour(s) ago
Health authorities are watching for signs the virus might be starting to accelerate again after a springtime lull in COVID rates.
Source: www.cbsnews.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1Rep. Beatty Stands Up for DEI in Medicine on House Floor - 7 hour(s) ago
In her speech, the Congresswoman called out H.R. 7725, the EDUCATE Act, which would restrict federal funding to medical schools that pursue DEI initiatives. …
Source: www.youtube.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study - 7 hour(s) ago
AbstractBackground and Aims. This trial sought to assess the safety and efficacy of ShortCut, the first dedicated leaflet modification device, prior to tra
Source: academic.oup.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0
Guest View If you are not affiliated with Stanford, use Guest View and your own licensed
Source: lane.stanford.eduCategories: General Medicine News, CardiologistsTweet
RT @ifixhearts: Watch my appearance on Meat for Mental Health here https://t.co/jcSUJTNNCy https://t.co/RzR2aRdEQb